Loading viewer...
investor_presentation
Format: PDF investor_presentation
Terumo Blood and Cell Technologies outlines its 5-year growth strategy with a 10-year vision, celebrating the company's 100th founding anniversary. The strategy targets near double-digit revenue growth and adjusted operating profit margins beyond 20% under the GS26 financial aspiration. Terumo aims to provide innovative solutions in blood and cell technologies to improve patient outcomes globally.
investor_presentation
16 Pages
investor_presentation
34 Pages
Iovance Biotherapeutics, Inc
investor_presentation
Roxgold
Converge Technology Solutions 2023 Investor Presentation
investor_presentationinvestor_presentation
27 Pages
Converge Technology Solutions